Open AccessA case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
Author(s) -
Meconi Federico,
Provenzano Ida,
Nasso Daniela,
Mariotti Benedetta,
Pupo Livio,
Secchi Roberto,
Cerretti Raffaella,
Lucia Anemona,
Arcese William,
Cantonetti Maria
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2898
Subject(s) - brentuximab vedotin , medicine , abvd , lymphoma , hodgkin lymphoma , oncology , disease , chemotherapy , vinblastine , hodgkin's lymphoma , vincristine , cyclophosphamide
Abstract Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T‐cell NHL.